Robert K Hills (Robert Hills)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Venues

British journal of haematology

University of Oxford

University of Leicester (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford Sep 01 2018

United Kingdom

Professor of Medical Statistics :: Nuffield Department of Population Health

Cardiff University Feb 01 2006 - Aug 31 2018

United Kingdom

Professor fo Tranlsational Statistics :: HCTU, CTR

Education History

University of Leicester

United Kingdom

MSC :: Medical Statistics

Publications

Robert K Hills
Acute myeloid leukaemia in Afghanistan: Understanding an unfamiliar landscape. British journal of haematology (2023)
Mhairi Copland, Cono Ariti, Ian F Thomas, Laura Upton, Mia Sydenham, Priyanka Mehta, Shahid Islam, Lars Kjeldsen, Alan K Burnett, Robert K Hills, Nigel H Russell, Mike Dennis, null null
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial. British journal of haematology (2023)
Robert K Hills
What drives CAR-T emergent cytopaenia? British journal of haematology (2023)
Nigel H Russell, Robert K Hills, Lars Kjeldsen, Richard E Clark, Sahra Ali, Paul Cahalin, Ian F Thomas, Alan K Burnett
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. British journal of haematology 198 (3) (2022)
Richard Dilon, Robert K Hills, Alan K Burnett, Nigel H Russell
Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials. British journal of haematology (2021)
David C Linch, Robert K Hills, Alan K Burnett, Nigel H Russell, Rosemary E Gale
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia. British journal of haematology (2021)
Nigel Russell, Robert K Hills, Lars Kjeldsen, Mike Dennis, Alan Burnett
Treatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trial. British journal of haematology 196 (6) (2021)
Mike Dennis, Alan Burnett, Robert K Hills, Ian Thomas, Cono Ariti, Marianne Tang Severinsen, Claire Hemmaway, Paul Greaves, Richard E Clark, Mhairi Copland, Nigel Russell, null null
A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial. British journal of haematology 194 (2) (2021)
Robert K Hills
High on-treatment platelet reactivity-an OPTIMAl solution, or a better solution? British journal of haematology (2021)
Sabine Kayser, Robert K Hills, Ralitsa Langova, Michael Kramer, Francesca Guijarro, Zuzana Sustkova, Elihu H Estey, Carole M Shaw, Zdenek Rácil, Jiri Mayer, Pavel Zak, Maria R Baer, Andrew M Brunner, Tomas Szotkowski, Petr Cetkovsky, David Grimwade, Roland Bruno Walter, Alan K Burnett, Anthony D Ho, Gerhard Ehninger, Carsten Müller-Tidow, Uwe Platzbecker, Christian Thiede, Christoph Röllig, Angela Schulz, Gregor Warsow, Benedikt Brors, Jordi Esteve, Nigel H Russell, Richard F Schlenk, Mark J Levis
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. British journal of haematology 192 (5) (2021)
Robert K Hills
Historical controls and venous thromboembolism prophylaxis in acute lymphoblastic leukaemia: things can only get better? British journal of haematology (2021)
Robert K Hills
Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'. British journal of haematology 193 (6) (2021)
David C Linch, Robert K Hills, Alan K Burnett, Rosemary E Gale
The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia. British journal of haematology 189 (3) (2020)
Joanna Zabkiewicz, Michelle Lazenby, Gareth Edwards, Ceri A Bygrave, Nader Omidvar, Lihui Zhuang, Steve Knapper, Carol Guy, Robert K Hills, Alan K Burnett, Caroline L Alvares
Combination of a mitogen-activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion-based residual disease and prevents re-expansion of FLT3-ITD acute myeloid leukaemia. British journal of haematology 191 (2) (2020)
Robert K Hills
Evaluating sixty years of UK trials research in acute myeloid leukaemia: lessons for trial design, past, present and future. British journal of haematology 188 (1) (2019)
David C Linch, Robert K Hills, Alan K Burnett, Nigel Russell, Rosemary E Gale
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia. British journal of haematology 188 (6) (2019)
Lauren Elston, Christopher Fegan, Robert K Hills, Shaikh S Hashimdeen, Elisabeth Walsby, Peter Henley, Christopher J Pepper, Stephen T Man
Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL. British journal of haematology 188 (6) (2019)
Alan K Burnett, Robert K Hills, Nigel Russell
Twenty five years of UK trials in acute myeloid leukaemia: what have we learned? British journal of haematology 188 (1) (2019)
Robert K Hills
Real world data and the art of maintenance therapy. British journal of haematology 184 (4) (2018)

Robert K Hills.css-eqlu8i{font-size:small;padding-left:4px;} (Robert Hills)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert K Hills (Robert Hills)